Huo X - Search Results

1

Case report of double superior vena cava and double odd vein with hypoplastic left brachiocephalic vein.

Lu H, Wang H, Huo X, Li G. Lu H, et al. Among authors: huo x. J Int Med Res. 2022 Sep;50(9):3000605221119655. doi: 10.1177/03000605221119655. J Int Med Res. 2022. PMID: 36071611 Free PMC article.

2

Impact of intestinal dysbiosis on breast cancer metastasis and progression.

Zhang J, Xie Q, Huo X, Liu Z, Da M, Yuan M, Zhao Y, Shen G. Zhang J, et al. Among authors: huo x. Front Oncol. 2022 Nov 7;12:1037831. doi: 10.3389/fonc.2022.1037831. eCollection 2022. Front Oncol. 2022. PMID: 36419880 Free PMC article. Review.

3

Treatment options for patients with human epidermal growth factor 2-positive breast cancer brain metastases: A systematic review and meta-analysis.

Huo X, Shen G, Wang T, Li J, Xie Q, Liu Z, Wang M, Zhao F, Ren D, Zhao J. Huo X, et al. Front Oncol. 2023 Feb 20;13:1003565. doi: 10.3389/fonc.2023.1003565. eCollection 2023. Front Oncol. 2023. PMID: 36890831 Free PMC article.

4

Meta-Analysis of HER2-Enriched Subtype Predicting the Pathological Complete Response Within HER2-Positive Breast Cancer in Patients Who Received Neoadjuvant Treatment.

Shen G, Zhao F, Huo X, Ren D, Du F, Zheng F, Zhao J. Shen G, et al. Among authors: huo x. Front Oncol. 2021 Jul 23;11:632357. doi: 10.3389/fonc.2021.632357. eCollection 2021. Front Oncol. 2021. PMID: 34367947 Free PMC article.

5

Watson for oncology decision system for treatment consistency study in breast cancer.

Liu Y, Huo X, Li Q, Li Y, Shen G, Wang M, Ren D, Zhao F, Liu Z, Zhao J, Liu X. Liu Y, et al. Among authors: huo x. Clin Exp Med. 2023 Sep;23(5):1649-1657. doi: 10.1007/s10238-022-00896-z. Epub 2022 Sep 22. Clin Exp Med. 2023. PMID: 36138331

6

Cyclin-dependent kinase 4 and 6 inhibitors in combination with neoadjuvant endocrine therapy in estrogen receptor-positive early breast cancer: a systematic review and meta-analysis.

Guan Y, Shen G, Fang Q, Xin Y, Huo X, Li J, Zhao F, Ren D, Liu Z, Li Z, Zhao J. Guan Y, et al. Among authors: huo x. Clin Exp Med. 2023 Jun;23(2):245-254. doi: 10.1007/s10238-022-00814-3. Epub 2022 Mar 19. Clin Exp Med. 2023. PMID: 35304677 Review.

7

Identification of the GTPase IMAP family as an immune-related prognostic biomarker in the breast cancer tumor microenvironment.

Huo X, Shen G, Li J, Wang M, Xie Q, Zhao F, Ren D, Dong Q, Zhao J. Huo X, et al. Gene. 2022 Feb 20;812:146094. doi: 10.1016/j.gene.2021.146094. Epub 2021 Dec 9. Gene. 2022. PMID: 34896519

8

Impact of platinum-based chemotherapy on the prognosis of early triple-negative breast cancer: a systematic review and meta-analysis.

Zhao F, Shen G, Dong Q, Xin Y, Huo X, Wang M, Liu Z, Zhao Y, Ren D, Xie Q, Liu Z, Li Z, Gao L, Du F, Zhao J. Zhao F, et al. Among authors: huo x. Clin Exp Med. 2023 Oct;23(6):2025-2040. doi: 10.1007/s10238-022-00940-y. Epub 2022 Nov 24. Clin Exp Med. 2023. PMID: 36422737 Review.

9

Second-line Endocrine Therapy of Hormone Receptor-positive/HER2- negative Advanced Breast Cancer: A Systematic Review and Network Meta-analysis.

Wang T, Shen G, Li J, Huo X, Wang M, Liu Z, Zhao F, Ren D, Zhao J. Wang T, et al. Among authors: huo x. Curr Cancer Drug Targets. 2023;23(9):718-730. doi: 10.2174/1568009623666230407101128. Curr Cancer Drug Targets. 2023. PMID: 37026492

10

Efficacy of anti-HER2 drugs in the treatment of patients with HER2-mutated cancers: a systematic review and meta-analysis.

Zheng Y, Shen G, Zhang C, Huo X, Xin Y, Fang Q, Guan Y, Zhao F, Ren D, Liu Z, Wang M, Zhao J. Zheng Y, et al. Among authors: huo x. Clin Exp Med. 2023 Nov;23(7):3205-3216. doi: 10.1007/s10238-023-01072-7. Epub 2023 Apr 30. Clin Exp Med. 2023. PMID: 37120775 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,097 results

Search Page

Filters